checkAd
    Startseite > Aktien > Zomedica > Nachrichten
    Zomedica Aktie
    0,1416
     
    USD
    -0,63 %
    -0,0009 USD
    Letzter Kurs 02:04:00 NYSE Arca
    0,1395
     
    USD
    100 STK
    Geldkurs 01.05.24
    0,1425
     
    USD
    140.000 STK
    Briefkurs 01.05.24
    ISIN: CA98980M1095 · WKN: A2QEF3 · SYM: ZOM · Kanada

    Neueste Nachrichten

    Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET
    30.04.24 · Accesswire · Zomedica
    Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
    09.04.24 · Accesswire · Zomedica
    Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
    01.04.24 · Accesswire · Zomedica
    Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
    20.03.24 · Accesswire · Zomedica
    Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
    14.03.24 · Accesswire · Zomedica
    Zomedica Provides NYSE American Listing Update
    13.03.24 · Accesswire · Zomedica
    Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences
    12.03.24 · Accesswire · Zomedica
    Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs
    07.03.24 · Accesswire · Zomedica
    Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024
    05.03.24 · Accesswire · Zomedica
    Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease
    18.12.23 · Accesswire · Zomedica
    Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners
    06.12.23 · Accesswire · Zomedica
    Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference
    28.11.23 · Accesswire · Zomedica